KRYS logo

Krystal Biotech (KRYS) Depreciation and amortization

annual D&A:

$6.71M+$803.00K(+13.58%)
December 31, 2024

Summary

  • As of today (June 26, 2025), KRYS annual depreciation & amortization is $6.71 million, with the most recent change of +$803.00 thousand (+13.58%) on December 31, 2024.
  • During the last 3 years, KRYS annual D&A has risen by +$4.87 million (+263.12%).
  • KRYS annual D&A is now at all-time high.

Performance

KRYS Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKRYSincome statement metrics

quarterly D&A:

$1.63M+$79.00K(+5.08%)
March 31, 2025

Summary

  • As of today (June 26, 2025), KRYS quarterly depreciation & amortization is $1.63 million, with the most recent change of +$79.00 thousand (+5.08%) on March 31, 2025.
  • Over the past year, KRYS quarterly D&A has increased by +$25.00 thousand (+1.55%).
  • KRYS quarterly D&A is now -19.15% below its all-time high of $2.02 million, reached on June 30, 2024.

Performance

KRYS quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKRYSincome statement metrics

TTM D&A:

$6.74M+$25.00K(+0.37%)
March 31, 2025

Summary

  • As of today (June 26, 2025), KRYS TTM depreciation & amortization is $6.74 million, with the most recent change of +$25.00 thousand (+0.37%) on March 31, 2025.
  • Over the past year, KRYS TTM D&A has increased by +$530.00 thousand (+8.54%).
  • KRYS TTM D&A is now -2.56% below its all-time high of $6.92 million, reached on September 30, 2024.

Performance

KRYS TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKRYSincome statement metrics

KRYS Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+13.6%+1.6%+8.5%
3 y3 years+263.1%+61.0%+189.5%
5 y5 years+516.0%+296.6%+391.9%

KRYS Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+263.1%-19.1%+290.0%-2.6%+189.5%
5 y5-yearat high+516.0%-19.1%+1301.5%-2.6%+391.9%
alltimeall timeat high>+9999.0%-19.1%+1301.5%-2.6%>+9999.0%

KRYS Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.63M(+5.1%)
$6.74M(+0.4%)
Dec 2024
$6.71M(+13.6%)
$1.55M(+1.7%)
$6.71M(-2.9%)
Sep 2024
-
$1.53M(-24.3%)
$6.92M(+2.4%)
Jun 2024
-
$2.02M(+25.6%)
$6.75M(+8.7%)
Mar 2024
-
$1.61M(-8.4%)
$6.21M(+5.0%)
Dec 2023
$5.91M(+74.6%)
$1.76M(+28.7%)
$5.91M(+29.3%)
Sep 2023
-
$1.36M(-7.6%)
$4.57M(+9.3%)
Jun 2023
-
$1.48M(+12.7%)
$4.18M(+13.6%)
Mar 2023
-
$1.31M(+212.9%)
$3.68M(+8.7%)
Dec 2022
$3.38M(+83.1%)
$419.00K(-57.0%)
$3.38M(+19.6%)
Sep 2022
-
$975.00K(-0.1%)
$2.83M(+7.3%)
Jun 2022
-
$976.00K(-3.8%)
$2.64M(+13.3%)
Mar 2022
-
$1.01M(-846.3%)
$2.33M(+25.9%)
Dec 2021
$1.85M(-0.1%)
-$136.00K(-117.4%)
$1.85M(-25.3%)
Sep 2021
-
$783.00K(+17.6%)
$2.48M(+14.1%)
Jun 2021
-
$666.00K(+24.3%)
$2.17M(+9.8%)
Mar 2021
-
$536.00K(+9.4%)
$1.98M(+6.7%)
DateAnnualQuarterlyTTM
Dec 2020
$1.85M(+69.8%)
$490.00K(+2.7%)
$1.85M(+9.0%)
Sep 2020
-
$477.00K(+1.1%)
$1.70M(+11.6%)
Jun 2020
-
$472.00K(+14.6%)
$1.52M(+11.1%)
Mar 2020
-
$412.00K(+22.3%)
$1.37M(+25.7%)
Dec 2019
$1.09M(+673.0%)
$337.00K(+12.0%)
$1.09M(+33.9%)
Sep 2019
-
$301.00K(-5.9%)
$814.00K(+47.7%)
Jun 2019
-
$320.00K(+142.4%)
$551.00K(+116.1%)
Mar 2019
-
$132.00K(+116.4%)
$255.00K(+80.9%)
Dec 2018
$141.00K(+513.0%)
$61.00K(+60.5%)
$141.00K(+50.0%)
Sep 2018
-
$38.00K(+58.3%)
$94.00K(+54.1%)
Jun 2018
-
$24.00K(+33.3%)
$61.00K(+52.5%)
Mar 2018
-
$18.00K(+28.6%)
$40.00K(+73.9%)
Dec 2017
$23.00K(+1050.0%)
$14.00K(+180.0%)
$23.00K(+155.6%)
Sep 2017
-
$5000.00(+66.7%)
$9000.00(+125.0%)
Jun 2017
-
$3000.00(+200.0%)
$4000.00(+300.0%)
Mar 2017
-
$1000.00
$1000.00
Dec 2016
$2000.00
-
-

FAQ

  • What is Krystal Biotech annual depreciation & amortization?
  • What is the all time high annual D&A for Krystal Biotech?
  • What is Krystal Biotech annual D&A year-on-year change?
  • What is Krystal Biotech quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Krystal Biotech?
  • What is Krystal Biotech quarterly D&A year-on-year change?
  • What is Krystal Biotech TTM depreciation & amortization?
  • What is the all time high TTM D&A for Krystal Biotech?
  • What is Krystal Biotech TTM D&A year-on-year change?

What is Krystal Biotech annual depreciation & amortization?

The current annual D&A of KRYS is $6.71M

What is the all time high annual D&A for Krystal Biotech?

Krystal Biotech all-time high annual depreciation & amortization is $6.71M

What is Krystal Biotech annual D&A year-on-year change?

Over the past year, KRYS annual depreciation & amortization has changed by +$803.00K (+13.58%)

What is Krystal Biotech quarterly depreciation & amortization?

The current quarterly D&A of KRYS is $1.63M

What is the all time high quarterly D&A for Krystal Biotech?

Krystal Biotech all-time high quarterly depreciation & amortization is $2.02M

What is Krystal Biotech quarterly D&A year-on-year change?

Over the past year, KRYS quarterly depreciation & amortization has changed by +$25.00K (+1.55%)

What is Krystal Biotech TTM depreciation & amortization?

The current TTM D&A of KRYS is $6.74M

What is the all time high TTM D&A for Krystal Biotech?

Krystal Biotech all-time high TTM depreciation & amortization is $6.92M

What is Krystal Biotech TTM D&A year-on-year change?

Over the past year, KRYS TTM depreciation & amortization has changed by +$530.00K (+8.54%)
On this page